Condition: Cervical Cancers · Sponsor: University of Alabama at Birmingham
This is a double-blind randomized controlled trial of 420 non-pregnant women undergoing cancer screening by visual inspection with acetic acid (VIA) who have Type 3 transformation zone (TZ) and randomized to receive either Misoprostol or placebo.
This description comes directly from the study's public registry record.
Warner K Huh, MD · 2059341555 · whuh@uabmc.edu
Simon M Manga, PhD · 2059345612 · smanga@uab.edu
Always discuss trial participation with your own doctor first.
| Cameroon Baptist Convention Health Core, EtougEbe Baptist Hospital Yaoundé | Yaoundé, Center Region, Cameroon | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06669533